Literature DB >> 34866619

Quantifying Levels of Dopaminergic Neuron Morphological Alteration and Degeneration in Caenorhabditis elegans.

Shefali R Bijwadia1, Katherine Morton1, Joel N Meyer2.   

Abstract

Dopamine neuron loss is involved in the pathology of Parkinson's Disease (PD), a highly prevalent neurodegenerative disorder affecting over 10 million people worldwide. Since many details about PD etiology remain unknown, studies investigating genetic and environmental contributors to PD are needed to discover methods of prevention, management, and treatment. Proper characterization of dopaminergic neuronal loss may be relevant not only to PD research, but to other increasingly prevalent neurodegenerative disorders. There are established genetic and chemical models of dopaminergic neurodegeneration in the Caenorhabditis elegans model system, with easy visualization of neurobiology supported by the nematodes' transparency and invariant neuronal architecture. In particular, hermaphroditic C. elegans' dopaminergic neuron morphological changes can be visualized using strains with fluorescent reporters driven by cell-specific promotors such as the dat-1 dopamine transporter gene, which is expressed exclusively in their eight dopaminergic neurons. With the capabilities of this model system and the appropriate technology, many laboratories have studied dopaminergic neurodegeneration. However, there is little consistency in the way the data is analyzed and much of the present literature uses binary scoring analyses that capture the presence of degeneration but not the full details of the progression of neuron loss. Here, we introduce a universal scoring system to assess morphological changes and degeneration in C. elegans' cephalic neuron dendrites. This seven-point scale allows for analysis across a full range of dendrite morphology, ranging from healthy neurons to complete dendrite loss, and considering morphological details including kinks, branching, blebs, and breaks. With this scoring system, researchers can quantify subtle age-related changes as well as more dramatic chemical-induced changes. Finally, we provide a practice set of images with commentary that can be used to train, calibrate, and assess the scoring consistency of researchers new to this method. This should improve within- and between- laboratory consistency, increasing rigor and reproducibility.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34866619      PMCID: PMC8815112          DOI: 10.3791/62894

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  38 in total

1.  Progressive degeneration of dopaminergic neurons through TRP channel-induced cell death.

Authors:  Archana Nagarajan; Ye Ning; Kaja Reisner; Zafir Buraei; Jan Petter Larsen; Oliver Hobert; Maria Doitsidou
Journal:  J Neurosci       Date:  2014-04-23       Impact factor: 6.167

2.  Strengths and limitations of morphological and behavioral analyses in detecting dopaminergic deficiency in Caenorhabditis elegans.

Authors:  Latasha L Smith; Ian T Ryde; Jessica H Hartman; Riccardo F Romersi; Zachary Markovich; Joel N Meyer
Journal:  Neurotoxicology       Date:  2019-07-16       Impact factor: 4.294

Review 3.  Genetics of Parkinson's disease.

Authors:  Christina M Lill
Journal:  Mol Cell Probes       Date:  2016-11-04       Impact factor: 2.365

Review 4.  Parkinson's disease: from monogenic forms to genetic susceptibility factors.

Authors:  Suzanne Lesage; Alexis Brice
Journal:  Hum Mol Genet       Date:  2009-04-15       Impact factor: 6.150

Review 5.  Ageing, neurodegeneration and Parkinson's disease.

Authors:  John V Hindle
Journal:  Age Ageing       Date:  2010-01-05       Impact factor: 10.668

6.  The genetics of Caenorhabditis elegans.

Authors:  S Brenner
Journal:  Genetics       Date:  1974-05       Impact factor: 4.562

7.  Mechanistic Investigations of the Mitochondrial Complex I Inhibitor Rotenone in the Context of Pharmacological and Safety Evaluation.

Authors:  Sabrina Heinz; Alexius Freyberger; Bettina Lawrenz; Ludwig Schladt; Gabriele Schmuck; Heidrun Ellinger-Ziegelbauer
Journal:  Sci Rep       Date:  2017-04-04       Impact factor: 4.379

8.  Application of a mathematical model to describe the effects of chlorpyrifos on Caenorhabditis elegans development.

Authors:  Windy A Boyd; Marjolein V Smith; Grace E Kissling; Julie R Rice; Daniel W Snyder; Christopher J Portier; Jonathan H Freedman
Journal:  PLoS One       Date:  2009-09-15       Impact factor: 3.240

9.  Meeting report: consensus statement-Parkinson's disease and the environment: collaborative on health and the environment and Parkinson's Action Network (CHE PAN) conference 26-28 June 2007.

Authors:  Jeff Bronstein; Paul Carvey; Honglei Chen; Deborah Cory-Slechta; Donato DiMonte; John Duda; Paul English; Samuel Goldman; Stephen Grate; Johnni Hansen; Jane Hoppin; Sarah Jewell; Freya Kamel; Walter Koroshetz; James W Langston; Giancarlo Logroscino; Lorene Nelson; Bernard Ravina; Walter Rocca; George W Ross; Ted Schettler; Michael Schwarzschild; Bill Scott; Richard Seegal; Andrew Singleton; Kyle Steenland; Caroline M Tanner; Stephen Van Den Eeden; Marc Weisskopf
Journal:  Environ Health Perspect       Date:  2008-08-26       Impact factor: 9.031

Review 10.  Modeling neurodegeneration in Caenorhabditis elegans.

Authors:  Kim A Caldwell; Corey W Willicott; Guy A Caldwell
Journal:  Dis Model Mech       Date:  2020-10-26       Impact factor: 5.758

View more
  2 in total

1.  Caenorhabditis elegans Neurotoxicity Testing: Novel Applications in the Adverse Outcome Pathway Framework.

Authors:  Shreesh Raj Sammi; Laura E Jameson; Kendra D Conrow; Maxwell C K Leung; Jason R Cannon
Journal:  Front Toxicol       Date:  2022-03-16

2.  Mild pentachlorophenol-mediated uncoupling of mitochondria depletes ATP but does not cause an oxidized redox state or dopaminergic neurodegeneration in Caenorhabditis elegans.

Authors:  Zachary R Markovich; Jessica H Hartman; Ian T Ryde; Kathleen A Hershberger; Abigail S Joyce; Patrick L Ferguson; Joel N Meyer
Journal:  Curr Res Toxicol       Date:  2022-08-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.